The €7bn - €7.5bn (US$6.39bn - US$6.84bn) sale of the Aventis Crop Science business unit to German pharmaceuticals and chemicals group Bayer , may not be completed by the end of this month. Klaus Pohle, CFO of Berlin-based Schering , holder of a 24% stake in ACS, told the